前往化源商城

Radiation Research 2010-11-01

Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers.

Charles A Kunos, Tomas Radivoyevitch, John Pink, Song-Mao Chiu, Tammy Stefan, James Jacobberger, Timothy J Kinsella

文献索引:Radiat. Res. 174(5) , 574-81, (2010)

全文:HTML全文

摘要

For repair of damaged DNA, cells increase de novo synthesis of deoxyribonucleotide triphosphates through the rate-limiting, p53-regulated ribonucleotide reductase (RNR) enzyme. In this study we investigated whether pharmacological inhibition of RNR by 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) enhanced chemoradiation sensitivity through a mechanism involving sustained DNA damage. RNR inactivation by 3-AP and resulting chemoradiosensitization were evaluated in human cervical (CaSki, C33-a) cancer cells through study of DNA damage (γ-H2AX signal) by flow cytometry, RNR subunit p53R2 and p21 protein steady-state levels by Western blot analysis and laser scanning imaging cytometry, and cell survival by colony formation assays. 3-AP treatment led to sustained radiation- and cisplatin-induced DNA damage (i.e. increased γ-H2AX signal) in both cell lines through a mechanism of inhibited RNR activity. Radiation, cisplatin and 3-AP exposure resulted in significantly elevated numbers and persistence of γ-H2AX foci that were associated with reduced clonogenic survival. DNA damage was associated with a rise in p53R2 but not p21 protein levels 6 h after treatment with radiation and/or cisplatin plus 3-AP. We conclude that blockage of RNR activity by 3-AP impairs DNA damage responses that rely on deoxyribonucleotide production and thereby may substantially increase chemoradiosensitivity of human cervical cancers.

相关化合物

结构式 名称/CAS号 全部文献
2-[(3-氨基吡啶-2-基)亚甲基]氨基硫脲 结构式 2-[(3-氨基吡啶-2-基)亚甲基]氨基硫脲
CAS:143621-35-6